Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Exchange Rate Effect (2019 - 2024)

Cyclerion Therapeutics has reported Exchange Rate Effect over the past 6 years, most recently at -$2000.0 for Q2 2024.

  • For Q2 2024, Exchange Rate Effect fell 166.67% year-over-year to -$2000.0; the TTM value through Mar 2025 reached -$2000.0, down 166.67%, while the annual FY2024 figure was -$6000.0, 175.0% down from the prior year.
  • Exchange Rate Effect for Q2 2024 was -$2000.0 at Cyclerion Therapeutics, up from -$4000.0 in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $8000.0 in Q4 2022 and troughed at -$12000.0 in Q2 2020.
  • A 5-year average of $142.86 and a median of $1000.0 in 2021 define the central range for Exchange Rate Effect.
  • Biggest five-year swings in Exchange Rate Effect: soared 400.0% in 2023 and later plummeted 500.0% in 2024.
  • Year by year, Exchange Rate Effect stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then surged by 166.67% to $8000.0 in 2022, then plummeted by 50.0% to $4000.0 in 2023, then tumbled by 150.0% to -$2000.0 in 2024.
  • Business Quant data shows Exchange Rate Effect for CYCN at -$2000.0 in Q2 2024, -$4000.0 in Q1 2024, and $4000.0 in Q4 2023.